Ltd. (CSPC) (01093.HK), a leading pharmaceutical group in China, jointly announced a strategic partnership between the two companies. Under the partnership, I-Mab's will grant an exclusive license ...

Analyst Sean Wu CFA from Morgan Stanley maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report) and keeping the price target at HK$12.00. Sean Wu CFA has given his Buy ...

Oct 7 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd (1093.HK), opens new tab in an exclusive licence agreement to ...